Uptake of HPV Vaccine among young adults with disabilities, 2011 to 2018 |
| |
| Institution: | 1. Department of Population and Quantitative Health Sciences, University of Massachusetts Chan Medical School, Worcester, MA, USA;2. Eunice Kennedy Shriver Center, University of Massachusetts Chan Medical School, Worcester, MA, USA;3. The Meyers Health Care Institute, A Joint Endeavor of the University of Massachusetts Chan Medical School, Fallon Health, and Reliant Medical Group, Worcester, MA, USA;4. Division of Geriatric Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA;1. University of Georgia, Ramsey Center, Room 349, 330 River Road, Athens, 30602, GA, USA;2. Old Dominion University, USA;1. School of Nursing, Psychotherapy, and Community Health, Dublin City University, Dublin, Ireland;2. College of Health Sciences, University of Delaware, Newark, DE, USA;3. KenCrest Services, Blue Bell, PA, USA;1. Centre for Disability Research and Policy, Faculty of Medicine and Health, University of Sydney, Sydney, NSW 2006, Australia;2. Centre of Research Excellence in Disability and Health, University of Sydney, Sydney, NSW, 2006, Australia;3. Centre for Disability Research, Faculty of Health & Medicine, Lancaster University, Lancaster, LA1 4YW, UK;1. The Lurie Institute for Disability Policy, The Heller School for Social Policy and Management, Brandeis University, 415 South Street, Waltham, MA, 02453, USA;2. Center for Healthcare Organization and Implementation Research (CHOIR), Bedford VA Healthcare System, 200 Spring Rd, Bedford, MA, 01730, USA;3. College of Health Professions, Virginia Commonwealth University, 907 Floyd Ave, Richmond, VA, 23284, USA;1. HAVAE UR20217 (Handicap, Aging, Autonomy, Environment), FEDRHA, University of Limoges, 87042, Limoges, France;2. Department of Physical Medicine and Rehabilitation in the University Hospital Center of Limoges, 87042, Limoges, France |
| |
| Abstract: | IntroductionLittle is known about human papillomavirus (HPV) vaccine uptake among young adults with disabilities (YAWD), despite this population having a higher risk of HPV infection and related cancers compared to the general population.ObjectiveTo compare the prevalence of HPV vaccination among young adults with disabilities to young adults without disabilities. We hypothesized that YAWD would have a lower prevalence of HPV vaccination than the general population.MethodsThis cross-sectional study used data for the years 2011 to 2018 of the National Health Interview Survey. Our analysis included 14,577 people (weighted n = 34,420,024) aged 18 to 26 years. Univariate and multivariable logistic models were used to estimate the role of disability on HPV vaccination uptake among young adults and to identify potential factors associated with HPV vaccination among YAWD.ResultsThe proportion of female and male YAWD with HPV vaccination was similar to those without disabilities, regardless of sex (Female Adjusted Odds Ratio (OR): 1.16; 95% Confidence Interval (CI): 0.91 to 1.48; Male Adjusted OR: 1.05; 95% CI: 0.69 to 1.60). Among female and male YAWD, the proportion with HPV vaccination was 56.1% and 28.5%, respectively. Other factors significantly associated with HPV vaccination among YAWD included age, country of birth, healthcare utilization, and insurance status.ConclusionsHPV vaccination among YAWD did not differ significantly from those without disabilities; however, the prevalence of HPV vaccination among young adult males and females remains significantly below national goals. Connecting young adults, specifically male YAWD, to the healthcare system is of utmost importance to improve HPV vaccination uptake. |
| |
| Keywords: | HPV Vaccination Young adults YAWD Vaccination |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
